세계의 바이러스성 간염 및 레트로바이러스 진단 검사 시장

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 바이러스성 간염 및 레트로바이러스 진단 검사 시장 규모는 분석기간(2020-2027년)에 8.5%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 33억 달러에서 2027년에는 59억 달러에 달할 것으로 예측됩니다.

세계의 바이러스성 간염 및 레트로바이러스 진단 검사 시장에 대해 조사했으며, 시장 점유율, 동향 및 전망, 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업의 예

• Abbott Diagnostics
• Chembio Diagnostic Systems, Inc.
• DiaSorin SpA
• Roche Diagnostics(Schweiz) AG

목차

I. 서론, 조사 방법, 조사 범위

II. 개요

• 시장 개요
  • 경쟁사의 시장 점유율
  • 경쟁사의 시장 점유율 시나리오
  • Covid-19의 영향과 다가오는 세계의 경기후퇴
• 주요 기업
• 동향과 성장요인
• 세계 시장의 전망

III. 시장 분석

• 지역별 시장 분석
• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 호주
• 인도
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 아르헨티나
• 브라질
• 멕시코
• 기타 라틴아메리카
• 중동
• 이란
• 이스라엘
• 사우디아라비아
• 아랍에미리트
• 기타 중동
• 아프리카

IV. 경쟁

• 기업 개요 : 31사

Abstract:

Global Viral Hepatitis and Retrovirus Diagnostic Tests Market to Reach $5.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Viral Hepatitis and Retrovirus Diagnostic Tests estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing at a CAGR of 8.5% over the period 2020-2027.

The U.S. Market is Estimated at $898.1 Million, While China is Forecast to Grow at 11.4% CAGR

The Viral Hepatitis and Retrovirus Diagnostic Tests market in the U.S. is estimated at US$898.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Select Competitors (Total 31 Featured) -

• Abbott Diagnostics
• Amkay Products
• AOV International
• Apothecaries Sundries Manufacturing
• BD
• Beckman Coulter
• Bhat Bio-tech
• BioMerieux
• Bioneovan
• Bio-Rad
• Cepheid
• Chembio
• DiaSorin
• Enzo Biochem
• Fujirebio
• Gemc Technology
• Grifols
• Hangzhou Deangel Biological Engineering
• Hangzhou Heo Bio-Tech
• Hologic
• Horiba
• Innovation Biotech
• Jaksh Enterprises
• Krishco Medical Products
• Roche Diagnostics

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • TABLE 2: World Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • TABLE 3: World 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

• UNITED STATES
  • TABLE 4: USA Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 5: USA Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• CANADA
  • TABLE 6: Canada Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 7: Canada Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• JAPAN
  • TABLE 8: Japan Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 9: Japan Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• CHINA
  • TABLE 10: China Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 11: China Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• EUROPE
  • TABLE 12: Europe Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • TABLE 13: Europe Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • TABLE 14: Europe 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
• FRANCE
  • TABLE 15: France Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 16: France Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• GERMANY
  • TABLE 17: Germany Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 18: Germany Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• ITALY
  • TABLE 19: Italy Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 20: Italy Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• UNITED KINGDOM
  • TABLE 21: UK Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 22: UK Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• SPAIN
  • TABLE 23: Spain Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 24: Spain Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• RUSSIA
  • TABLE 25: Russia Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 26: Russia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• REST OF EUROPE
  • TABLE 27: Rest of Europe Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 28: Rest of Europe Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• ASIA-PACIFIC
  • TABLE 29: Asia-Pacific Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • TABLE 30: Asia-Pacific Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • TABLE 31: Asia-Pacific 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
• AUSTRALIA
  • TABLE 32: Australia Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 33: Australia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• INDIA
  • TABLE 34: India Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 35: India Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• SOUTH KOREA
  • TABLE 36: South Korea Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 37: South Korea Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• REST OF ASIA-PACIFIC
  • TABLE 38: Rest of Asia-Pacific Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 39: Rest of Asia-Pacific Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• LATIN AMERICA
  • TABLE 40: Latin America Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • TABLE 41: Latin America Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • TABLE 42: Latin America 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
• ARGENTINA
  • TABLE 43: Argentina Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 44: Argentina Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• BRAZIL
  • TABLE 45: Brazil Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 46: Brazil Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• MEXICO
  • TABLE 47: Mexico Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 48: Mexico Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• REST OF LATIN AMERICA
  • TABLE 49: Rest of Latin America Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 50: Rest of Latin America Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• MIDDLE EAST
  • TABLE 51: Middle East Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • TABLE 52: Middle East Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • TABLE 53: Middle East 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
• IRAN
  • TABLE 54: Iran Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 55: Iran Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• ISRAEL
  • TABLE 56: Israel Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 57: Israel Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• SAUDI ARABIA
  • TABLE 58: Saudi Arabia Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 59: Saudi Arabia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• UNITED ARAB EMIRATES
  • TABLE 60: UAE Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 61: UAE Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• REST OF MIDDLE EAST
  • TABLE 62: Rest of Middle East Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 63: Rest of Middle East Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• AFRICA
  • TABLE 64: Africa Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • TABLE 65: Africa Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR

IV. COMPETITION

• Total Companies Profiled: 31